Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study
- PMID: 35189083
- PMCID: PMC8856663
- DOI: 10.1016/S2352-4642(22)00027-X
Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study
Abstract
Background: South Africa reported a notable increase in COVID-19 cases from mid-November, 2021, onwards, starting in Tshwane District, which coincided with the rapid community spread of the SARS-CoV-2 omicron (B.1.1.529) variant. This increased infection rate coincided with a rapid increase in paediatric COVID-19-associated admissions to hospital (hereafter referred to as hospitalisations).
Methods: The Tshwane Maternal-Child COVID-19 study is a multicentre observational study in which we investigated the clinical manifestations and outcomes of paediatric patients (aged ≤19 years) who had tested positive for SARS-CoV-2 and were admitted to hospital for any reason in Tshwane District during a 6-week period at the beginning of the fourth wave of the COVID-19 epidemic in South Africa. We used five data sources, which were: (1) COVID-19 line lists; (2) collated SARS-CoV-2 testing data; (3) SARS-CoV-2 genomic sequencing data; (4) COVID-19 hospitalisation surveillance; and (5) clinical data of public sector COVID-19-associated hospitalisations among children aged 13 years and younger.
Findings: Between Oct 31 and Dec 11, 2021, 6287 children and adolescents in Tshwane District were recorded as having COVID-19. During this period, 2550 people with COVID-19 were hospitalised, of whom 462 (18%) were aged 19 years or younger. The number of paediatric cases was higher than in the three previous SARS-CoV-2 waves, uncharacteristically increasing ahead of adult hospitalisations. 75 viral samples from adults and children in the district were sequenced, of which 74 (99%) were of the omicron variant. Detailed clinical notes were available for 138 (75%) of 183 children aged ≤13 years with COVID-19 who were hospitalised. 87 (63%) of 138 children were aged 0-4 years. In 61 (44%) of 138 cases COVID-19 was the primary diagnosis, among whom symptoms included fever (37 [61%] of 61), cough (35 [57%]), shortness of breath (19 [31%]), seizures (19 [31%]), vomiting (16 [26%]), and diarrhoea (15 [25%]). Median length of hospital stay was 2 days [IQR 1-3]). 122 (88%) of 138 children with available data needed standard ward care and 27 (20%) needed oxygen therapy. Seven (5%) of 138 children were ventilated and four (3%) died during the study period, all related to complex underlying copathologies. All children and 77 (92%) of 84 parents or guardians with available data were unvaccinated to COVID-19.
Interpretation: Rapid increases in paediatric COVID-19 cases and hospitalisations mirror high community transmission of the SARS-CoV-2 omicron variant in Tshwane District, South Africa. Continued monitoring is needed to understand the long-term effect of the omicron variant on children and adolescents.
Funding: South African Medical Research Council, South African Department of Science & Innovation, G7 Global Health Fund.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures



Comment in
-
SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge.Lancet Child Adolesc Health. 2022 May;6(5):280-281. doi: 10.1016/S2352-4642(22)00060-8. Epub 2022 Feb 18. Lancet Child Adolesc Health. 2022. PMID: 35189084 Free PMC article. No abstract available.
Similar articles
-
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.Int J Infect Dis. 2022 Mar;116:38-42. doi: 10.1016/j.ijid.2021.12.357. Epub 2021 Dec 28. Int J Infect Dis. 2022. PMID: 34971823 Free PMC article.
-
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.Lancet Glob Health. 2022 Jul;10(7):e961-e969. doi: 10.1016/S2214-109X(22)00114-0. Epub 2022 May 18. Lancet Glob Health. 2022. PMID: 35597249 Free PMC article.
-
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.Lancet Infect Dis. 2022 Jul;22(7):967-976. doi: 10.1016/S1473-3099(22)00154-2. Epub 2022 Apr 22. Lancet Infect Dis. 2022. PMID: 35468331 Free PMC article.
-
The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children.Front Pediatr. 2022 Aug 2;10:898463. doi: 10.3389/fped.2022.898463. eCollection 2022. Front Pediatr. 2022. PMID: 35983081 Free PMC article. Review.
-
Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.J Med Virol. 2022 May;94(5):1876-1885. doi: 10.1002/jmv.27626. Epub 2022 Feb 3. J Med Virol. 2022. PMID: 35083761 Free PMC article. Review.
Cited by
-
Clinical characteristics of children with omicron SARS-CoV-2 infection in Changchun, China from march to april 2022: A retrospective study.Front Pediatr. 2022 Nov 15;10:990944. doi: 10.3389/fped.2022.990944. eCollection 2022. Front Pediatr. 2022. PMID: 36458144 Free PMC article.
-
Clinical characteristics, treatment and prognosis of children with SARS-CoV-2 infection complicated with severe neurological dysfunctions in Foshan, China.Front Pediatr. 2024 Aug 16;12:1414023. doi: 10.3389/fped.2024.1414023. eCollection 2024. Front Pediatr. 2024. PMID: 39220151 Free PMC article.
-
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19.Diagnostics (Basel). 2023 Feb 2;13(3):559. doi: 10.3390/diagnostics13030559. Diagnostics (Basel). 2023. PMID: 36766664 Free PMC article. Review.
-
Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.JAMA. 2022 Jun 28;327(24):2452-2454. doi: 10.1001/jama.2022.8025. JAMA. 2022. PMID: 35588048 Free PMC article.
-
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis.J Gene Med. 2022 Jul;24(7):e3435. doi: 10.1002/jgm.3435. Epub 2022 Jun 30. J Gene Med. 2022. PMID: 35726542 Free PMC article. Review.
References
-
- WHO . World Health Organization; 2021. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern.https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1....
-
- Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021;600:21. - PubMed
Uncited References
-
- Lancet Laboratories Respiratory virus statistics. November, 2021. https://www.lancet.co.za/respiratory-virus-statistics-for-november-2021/
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous